Based on Propensity Matching Scores: Comparison of the Mid-term Outcomes of Two Bariatric Surgeries for the Treatment of Obesity and its Complications - Summary - MDSpire
Advertisement
Based on Propensity Matching Scores: Comparison of the Mid-term Outcomes of Two Bariatric Surgeries for the Treatment of Obesity and its Complications
To compare the medium-term efficacy (specify duration, e.g., 1-3 years) of sleeve gastrectomy (SG) and single anastomotic duodeno-ileal bypass with sleeve gastrectomy (SADI-S) in treating obesity and its complications in an Asian population.
Key Findings:
SG was performed in 134 patients and SADI-S in 52 patients, highlighting the need for further research on SADI-S due to its lower adoption.
SADI-S is recommended for patients with higher BMI and more severe metabolic comorbidities, indicating its targeted use.
Postoperative outcomes including weight loss and metabolic disease remission were evaluated, showing significant differences between the two groups.
Interpretation:
The study aims to provide clinical evidence on the comparative effectiveness of SG and SADI-S, addressing a gap in existing literature regarding mid- to long-term outcomes.
Limitations:
Retrospective design may introduce selection bias, potentially affecting the reliability of the findings.
Limited sample size for SADI-S may affect generalizability, suggesting the need for larger studies.
Follow-up duration may not capture all long-term outcomes, indicating a need for extended studies to assess sustainability.
Conclusion:
The study seeks to clarify the mid-term outcomes of SG versus SADI-S, contributing to informed surgical decision-making for obesity treatment and highlighting the need for further research in this area.
A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation
A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.
